CSCI (Cosciens Biopharma) Interest Expense : $-0.09 Mil (TTM As of Dec. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Cosciens Biopharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cosciens Biopharma's interest expense for the three months ended in Dec. 2024 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.09 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cosciens Biopharma's Operating Income for the three months ended in Dec. 2024 was $ -3.61 Mil. Cosciens Biopharma's Interest Expense for the three months ended in Dec. 2024 was $ -0.02 Mil. Cosciens Biopharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cosciens Biopharma Interest Expense Historical Data

The historical data trend for Cosciens Biopharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosciens Biopharma Interest Expense Chart

Cosciens Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.14

-0.12

-0.14

-0.13

Cosciens Biopharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.02	-0.02	-0.02	-0.02

Cosciens Biopharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.09 Mil.

Cosciens Biopharma (NAS:CSCI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cosciens Biopharma's Interest Expense for the three months ended in Dec. 2024 was $-0.02 Mil. Its Operating Income for the three months ended in Dec. 2024 was $-3.61 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was $2.04 Mil.

Cosciens Biopharma's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Cosciens Biopharma did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Cosciens Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cosciens Biopharma Inc (NAS:CSCI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ET8:Germany CSCI:Canada

Address

c/o Norton Rose Fulbright Canada LLP, 222 Bay Street, Suite 3000, P.O. Box 53, Toronto, ON, CAN, M5K 1E7

Website

https://www.zentaris.com

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.